Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Booming Drug Sales Make This San Diego Biotech a Prime M&A Target November 2, 2017 5 Things Illumina's Management Wants You to Know February 1, 2017 Laurus Labs PAT Grows By 40%; Board Recommends A Dividend Of 15% May 18, 2017
